These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16996800)

  • 1. TRPV1: a therapeutic target for novel analgesic drugs?
    Szallasi A; Cruz F; Geppetti P
    Trends Mol Med; 2006 Nov; 12(11):545-54. PubMed ID: 16996800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain TRPV1: a depressing TR(i)P down memory lane?
    Di Marzo V; Gobbi G; Szallasi A
    Trends Pharmacol Sci; 2008 Dec; 29(12):594-600. PubMed ID: 18947889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.
    Szallasi A; Cortright DN; Blum CA; Eid SR
    Nat Rev Drug Discov; 2007 May; 6(5):357-72. PubMed ID: 17464295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPV1 antagonists: the challenges for therapeutic targeting.
    Khairatkar-Joshi N; Szallasi A
    Trends Mol Med; 2009 Jan; 15(1):14-22. PubMed ID: 19097938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.
    Niiyama Y; Kawamata T; Yamamoto J; Omote K; Namiki A
    Neuroscience; 2007 Aug; 148(2):560-72. PubMed ID: 17656027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia.
    Honore P; Chandran P; Hernandez G; Gauvin DM; Mikusa JP; Zhong C; Joshi SK; Ghilardi JR; Sevcik MA; Fryer RM; Segreti JA; Banfor PN; Marsh K; Neelands T; Bayburt E; Daanen JF; Gomtsyan A; Lee CH; Kort ME; Reilly RM; Surowy CS; Kym PR; Mantyh PW; Sullivan JP; Jarvis MF; Faltynek CR
    Pain; 2009 Mar; 142(1-2):27-35. PubMed ID: 19135797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
    Wong GY; Gavva NR
    Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
    Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
    Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot receptors in the brain.
    Steenland HW; Ko SW; Wu LJ; Zhuo M
    Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation.
    Alawi K; Keeble J
    Pharmacol Ther; 2010 Feb; 125(2):181-95. PubMed ID: 19896501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.
    Gunthorpe MJ; Chizh BA
    Drug Discov Today; 2009 Jan; 14(1-2):56-67. PubMed ID: 19063991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans.
    Chizh BA; O'Donnell MB; Napolitano A; Wang J; Brooke AC; Aylott MC; Bullman JN; Gray EJ; Lai RY; Williams PM; Appleby JM
    Pain; 2007 Nov; 132(1-2):132-41. PubMed ID: 17659837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
    Knotkova H; Pappagallo M; Szallasi A
    Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TRPV1 receptors in descending modulation of pain.
    Palazzo E; Rossi F; Maione S
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S79-83. PubMed ID: 18325659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
    De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice.
    Baiou D; Santha P; Avelino A; Charrua A; Bacskai T; Matesz K; Cruz F; Nagy I
    J Comp Neurol; 2007 Jul; 503(2):334-47. PubMed ID: 17492627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo.
    Christoph T; Grünweller A; Mika J; Schäfer MK; Wade EJ; Weihe E; Erdmann VA; Frank R; Gillen C; Kurreck J
    Biochem Biophys Res Commun; 2006 Nov; 350(1):238-43. PubMed ID: 16996476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis.
    Xu GY; Winston JH; Shenoy M; Yin H; Pendyala S; Pasricha PJ
    Gastroenterology; 2007 Oct; 133(4):1282-92. PubMed ID: 17698068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of rat sensory neuron-specific receptor (rSNSR1) in inflammatory pain: contribution of TRPV1 to SNSR signaling in the pain pathway.
    Ndong C; Pradhan A; Puma C; Morello JP; Hoffert C; Groblewski T; O'Donnell D; Laird JM
    Pain; 2009 May; 143(1-2):130-7. PubMed ID: 19307060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.